Innoviva, Inc.
(NASDAQ : INVA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
PTLAPortola Pharmaceuticals, Inc. -0.08%17.846.5%$160.95m
HZNPHorizon Therapeutics Plc 2.24%49.846.5%$140.73m
MYOKMyoKardia, Inc. 0.08%100.231.8%$126.56m
BHCBausch Health Cos., Inc. -1.13%18.370.0%$118.73m
CTLTCatalent, Inc. 1.30%77.902.3%$111.02m
VRXValeant Pharmaceuticals International, Inc. -1.18%18.3614.1%$108.03m
UTHRUnited Therapeutics Corp. 0.28%115.3214.3%$74.70m
AMRNAmarin Corp. Plc -2.64%6.651.6%$58.54m
ICPTIntercept Pharmaceuticals, Inc. -2.63%70.8316.8%$57.34m
JAZZJazz Pharmaceuticals Plc -0.09%118.692.4%$57.14m
GWPHGW Pharmaceuticals Plc -1.88%123.106.2%$55.76m
ARGXargenx SE 0.60%212.940.0%$49.87m
AXSMAxsome Therapeutics, Inc. -3.26%74.021.9%$49.02m
ICLRICON plc -0.53%164.744.3%$44.03m
PRGOPerrigo Co. Plc -2.76%53.516.8%$43.94m

Company Profile

Innoviva, Inc. is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.